Trending Topics

 

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

The 2016 ASTRO Annual Meeting will take place in Boston from September 25 to 28. Featuring new insights and discoveries from leading institutions around the world, this scientific forum will include presentations and data that could affect the way cancer care is planned and delivered. Memorial Sloan Kettering radiation oncologists are available to comment on meeting news and presentations. Follow the meeting live on Twitter using the hashtag #ASTRO16. For more information or to speak with an expert, contact mediastaff@mskcc.org.
Friday, September 23, 2016
 
A new drug is being shown to extend the lives of patients with advanced soft tissue sarcoma by almost a year. The results of a multicenter phase II trial evaluating the efficacy and safety of olaratumab in combination with doxorubicin chemotherapy was published in The Lancet on June 9. William Tap, MD, Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), served as corresponding author on this study, which met its primary endpoint of progression-free survival and showed a statistically significant improvement in overall survival. To arrange an interview with Dr. Tap, please email mcnamarn@mskcc.org.
Friday, June 10, 2016
 
MSK researchers are presenting nearly 120 studies at the 2016 Annual Meeting of the American Society of Clinical Oncology.
Friday, June 3, 2016
 
See all trending topics
 

Press Releases

 
In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with us for initial or ongoing cancer care.
Wednesday, September 21, 2016
 
Men with metastatic prostate cancer should be considered for germline genetic testing of DNA repair genes, regardless of age or family history, according to a team of researchers from Memorial Sloan Kettering Cancer Center (MSK), Fred Hutchinson Cancer Research Center, Dana-Farber Cancer Institute, University of Washington School of Medicine, University of Michigan, and the Institute of Cancer Research Royal Marsden Hospital.
Wednesday, July 6, 2016
 
Memorial Sloan Kettering Cancer Center (MSK) molecular pharmacologist Daniel Heller, PhD, and colleagues have identified a new strategy to target drugs specifically to cancer sites, including metastatic tumors. The approach involves nanoparticles designed to mimic a mechanism that tumors themselves use to metastasize throughout the body. This work, which will be featured on the cover of the June 29 issue of Science Translational Medicine, was applicable across a wide range of tumor and drug types and can potentially be applied to other conditions including vascular and autoimmune diseases.
Wednesday, June 29, 2016
 
See all press releases
 

On Our Blog

 
FINDING
Researchers have found two gene mutations that many exceptional responders to ipilimumab have in common.
Wednesday, September 28, 2016
 
IN THE CLINIC
MSK’s Kathryn Beal presents new findings on combining radiation with immunotherapy for brain cancer.
Tuesday, September 27, 2016
 
FEATURE
Bone marrow transplants can be a lifesaving treatment for cancer patients, many of whom rely on cells from unrelated donors.
Tuesday, September 27, 2016
 
See all blog posts
 

Media Coverage

 
Medical oncologist Andrew Epstein was interviewed about pain and palliative care in HealthDay News. 
Wednesday, September 21, 2016
 
MSK’s Teen and Young Adult Program, TYA@MSK, is featured in The Huffington Post. 
Sunday, September 18, 2016
 
Medical oncologist Jacqueline Bromberg discusses inflammatory breast cancer with The Huffington Post
Sunday, September 18, 2016
 
See all media coverage
 

If you wish to contact MSK about a marketing or advertising related opportunity, or are looking for additional information about our ad campaign, please email us at marketing@mskcc.org.

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
 
Emily O'Donnell
Senior Communications Associate, Department of Surgery
 
Courtney Nowak
Senior Media Relations Associate
 
Caitlin Hool
Senior Media Associate
 
Nicole H. McNamara
Senior Media Relations Associate
 
Rebecca Williams
Media Associate
 
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
 
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to the News@MSKCC newsletter

Our email newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign up

Unsubscribe »